Picture of Vitaminka AD Prilep logo

VITA Vitaminka AD Prilep Income Statement

0.000.00%
mk flag iconLast trade - 00:00
Consumer DefensivesBalancedMicro CapNeutral

Annual income statement for Vitaminka AD Prilep, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,1442,2832,3512,8243,651
Cost of Revenue
Gross Profit763765805795872
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses2,0832,2332,2852,7043,530
Operating Profit60.650.266.5120121
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes3519.929.383.275.3
Provision for Income Taxes
Net Income After Taxes28.818.125.876.269.8
Net Income Before Extraordinary Items
Net Income28.818.125.876.269.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income28.818.125.876.269.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS522263362953907
Dividends per Share